spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

ChinaBio® Partnering Forum 2019

8-9 May 2019
Shanghai, China

Access a world of opportunities through life science partnering in China. ChinaBio® Partnering Forum is the premier life science partnering event in China. The conference will be held May 8–9 in Shanghai, attracting biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.

For the event’s eleventh anniversary, we expect over 1,400 delegates from more than 500 companies and 25 countries to attend, making it the largest partnering conference in China. The 2019 edition promises attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes.

The conference also features partneringONE®, the gold standard partnering platform enabling delegates to efficiently identify, meet and network with companies from across the life science value chain.

Producers: EBD Group and ChinaBio® Group EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

Contacts:
In China
Jean Meng
ChinaBio® LLC
+86 21 5137 0751 ext 20
From the USA: +1 858 926 4566
jean.meng@chinabio.com

In the EU/USA
Philipp Dormeier
EBD Group +49 89 23 88 756 42
pdormeier@ebdgroup.com

Visa, Travel and Hotel Contact:
Lynn Luo
T: +86 21 5137 0751
lynn.luo@chinabio.com

Industry:
Biotech

Key words:

partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, China, life science, cross border

Intended for:
● Senior executives of leading China-based pharma and biotech companies
● Senior management and business development executives from global biotech and pharma companies
● Venture capitalists and other investors active in life science

Cost:
https://ebdgroup.knect365.com/chinabio-partnering/purchase/select-package

Program, Speakers:
https://ebdgroup.knect365.com/chinabio-partnering/agenda/1
 
Print this page
Send to a friend
   
spacer
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>


News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement